Next Article in Journal
From LI-RADS Classification to HCC Pathology: A Retrospective Single-Institution Analysis of Clinico-Pathological Features Affecting Oncological Outcomes after Curative Surgery
Previous Article in Journal
Primary Pericardial Synovial Sarcoma: A Case Report and Literature Review
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Case Report

Second Trimester Fetal Loss Due to Citrobacter koseri Infection: A Rare Cause of Preterm Premature Rupture of Membranes (PPROM)

1
Pathology Unit, Azienda USL-IRCCS di Reggio Emilia, 42123 Reggio Emilia, Italy
2
Department of Obstetrics & Gynaecology, Azienda USL-IRCCS di Reggio Emilia, 42123 Reggio Emilia, Italy
3
Clinical Microbiology Laboratory, Azienda USL-IRCCS di Reggio Emilia, 42123 Reggio Emilia, Italy
4
Pathology Unit, “Maggiore della Carità” Hospital, 28100 Novara, Italy
*
Author to whom correspondence should be addressed.
Diagnostics 2022, 12(1), 159; https://doi.org/10.3390/diagnostics12010159
Submission received: 15 November 2021 / Revised: 30 December 2021 / Accepted: 6 January 2022 / Published: 10 January 2022
(This article belongs to the Section Diagnostic Microbiology and Infectious Disease)

Abstract

:
Citrobacter koseri is a facultative anaerobic, motile, non-spore-forming Gram-negative bacillus, which belongs to the family of Enterobacteriaceae. Severe infections due to Citrobacter spp. have been reported in the urinary tract, respiratory airways, intra-abdominal organs, skin and soft tissue, eye, bone, bloodstream, and central nervous system. In newborns, C. koseri is a well-known cause of meningitis, cerebral abscesses, brain adhesions, encephalitis, and pneumocephalus. Infection can be acquired through vertical maternal transmission or horizontal hospital settings; however, in many cases, the source is unknown. Preterm premature rupture of membranes (PPROM), caused by C. koseri, has rarely been described. Herein, we describe a case of PPROM at 16 weeks and 3 days of gestation, leading to anhydramnios. The parents opted for legal termination of the pregnancy, as the prognosis was very poor. C. koseri was isolated postmortem from a placental subamniotic swab and parenchymal sample, as well as fetal blood and lung. To the best of our knowledge, this is the first case of early second-trimester PPROM in which C. koseri infection was demonstrated.

1. Introduction

Citrobacter koseri (formerly Citrobacter diversus) belongs to the family of Enterobacteriaceae, and is a facultative anaerobic, motile, non-spore-forming Gram-negative bacillus. Citrobacter species are commonly found in water, soil, sewage, food, and occasional colonizers of the gastrointestinal tract of animals and humans. Citrobacter spp. may cause severe infections in the urinary tract, respiratory airways, intra-abdominal organs, skin and soft tissue, eye, bone, bloodstream, and central nervous system [1].
In neonates, C. koseri infection is responsible for meningitis, cerebral abscesses, brain adhesions, encephalitis, ventriculitis, and pneumocephalus [2,3,4,5,6,7]. The bacterium is acquired from vertical maternal transmission at delivery or through horizontal nosocomial spread, but, in most cases, the origin remains unknown [3].
Vertical transmission is more likely if the symptoms occur in the first days of life, although isolation of the pathogen in the mother is uncommon. In general, C. koseri infection in newborns occurs sporadically, and it is classified in early onset (between 5 and 12 days of age) and late onset (around 4–5 weeks of age) [3].
Clinical manifestations of central nervous system infection are similar to other pathogens, such as poor feeding, vomiting, hypotonia, seizures, lethargy, fever, and bulging fontanelle. The main complication is meningitis, due to a 32 kDa protein present in the external membrane of the bacteria. Brain abscesses are extremely frequent in C. koseri meningitis, occurring in almost 80% of cases, compared to 1% of other etiologies. Conversely, the mortality rate in C. koseri meningitis is around 30%, and neurological sequelae are reported in more than 80% of cases [3,4,5]. Infant management must be prompt, and includes clinical evaluation, blood and urine cultures, and lumbar puncture for cerebrospinal fluid examination. Antibiotic therapy must be given according to antimicrobial susceptibility testing results. Serial magnetic resonance imaging (MRI) is the gold standard in detecting early cerebral complications [4].
Although C. koseri infection in infants is well recognized, it has rarely been described in prenatal settings as a cause of preterm premature rupture of membranes (PPROM) [8].
We report a new case of PPROM at 16 weeks and 3 days of gestation, which resulted in legal termination of the pregnancy, due to anhydramnios and adverse outcomes. C. koseri was isolated postmortem from the placental swab and tissue, as well as fetal blood and lung. To the best of our knowledge, this is the first case of early second-trimester PPROM caused by C. koseri infection.

2. Case Description

A 39-year-old woman was admitted to the emergency department of our institution for abundant vaginal bleeding and PPROM at 16 weeks and 3 days of gestation. The patient was nulliparous with a history of cervical insufficiency and recurrent spontaneous abortion (RSA). She had six previous miscarriages, and two of them underwent fetal autopsies at our institution. Both of them occurred at 19 weeks of gestation (wga), and the prenatal ultrasound (US) showed no anomalies and regular fetal growth, which was confirmed by the autopsy. Unfortunately, microbiological cultures were not performed. The first miscarriage presented with vaginal bleeding, despite a cervical prophylactic cerclage. Histologically, there was acute chorioamnionitis, but neutrophils were not found in the fetal tissues. The second miscarriage presented with PPROM and anhydramnios. Microscopy showed acute chorioamnionitis and chorionic vasculitis. Abundant neutrophils were found in the fetal lung within the bronchi and alveoli, as well as into the gastric, and small and large intestine contents.
Regarding the current miscarriage, the US prenatal findings were within the normal limits. The patient had a prophylactic cervical cerclage (Shirodkar type) positioned 17 days before the PPROM. At admission, the vaginal swab and urine culture were negative. She was started on antibiotics according to the PPROM guidelines [9], and was treated with ampicillin (2 g intravenous injection every 6 h) for 2 days, which was then replaced with amoxicillin (1 g capsule every 8 h for 3 days, and reduced to 1 g capsule every 12 h for 3 days). However, despite the medical therapy, at day four of hospitalization, the fetal conditions worsened with anhydramnios and the patient opted for legal termination of the pregnancy. Labour was induced and a stillborn female baby was delivered at 17 wga. The patient was discharged two days after the procedure in good health and she was given chlorhexidine in vaginal ovules for one week.
Postmortem examination revealed a nonmacerated fetus weighing 145 g and measuring 19 cm in crown–heel length. The other measurements were as follows: crown–rump length: 13 cm; foot length: 2.2 cm; head, chest, and abdominal circumference: 13 cm, 10.5 cm, and 9.5 cm, respectively. Overall, the anthropometric measurements were consistent with 17 weeks gestation [10]. External examination showed a normal female fetus with mild facial and nuchal edema. Internal examination disclosed organ congestion and moderate pericardial, pleural, and abdominal serous effusions. No congenital anomalies were found. Microscopic analysis revealed the presence of only rare intra-alveolar and gastric neutrophils. No other significant histological findings were noted.
The placenta was received complete, weighing 96 g and measuring 11 × 9 × 2 cm. Macroscopically, the placenta was pale, with an intra-parenchymal hematoma measuring 2 × 1 × 1 cm. The membranes were mildly opaque. Microscopically, there was acute chorioamnionitis (AC), corresponding to a stage 2/3 and grade 1/2 maternal inflammatory response [11]. Acute necrotizing deciduitis was also identified. A recent intraparenchymal thrombohematoma was confirmed, as identified grossly.
After the autopsy, the subamniotic swab and placental tissue of the patient, as well as the blood (collected through intracardiac sampling), lung, and liver of the fetus, were sent to the microbiology laboratory. Autoptical samples were cultured on Columbia blood agar (CBA), McConkey agar (MCA), mannitol salt agar (MSA), and Sabouraud (SAB) agar (all these media were incubated at 36 °C in ambient air), as well as chocolate agar (CA, incubated at 36 °C in 5% CO2) and Schaedler agar (SA, incubated at 36 °C in anaerobic atmosphere). After 24 h, the CBA plates of fetal blood, lung, subamniotic swab, and placental tissue yielded 2–4 mm in diameter, smooth, low, convex, and moist colonies, which were also present on MCA, CA, and SA. No growth was observed on MSA and SAB. The colonies were identified as Citrobacter koseri using the MALDI-ToF technology (Bruker Daltonics, Bremen, Germany), Biotyper OC software version 3.1. Fetal liver cultures remained negative. Antimicrobial susceptibility testing was performed using Phoenix 100™ (Becton Dickinson, Franklin Lakes, NJ, USA) and showed a wild-type antibiotype, displaying that the isolates were resistant to aminopenicillins only.

3. Discussion

Neonatal infection caused by C. koseri is a well-known entity, albeit uncommon. It typically causes sepsis, meningitis, encephalitis, and brain abscesses. Premature infants are more susceptible, and the overall prognosis is very poor, with high morbidity and mortality. C. koseri colonization of the lower gastrointestinal tract, respiratory tract, and oral cavity may be responsible for horizontal transmission from healthcare workers in hospitals or in the community from family members. Vertical transmission from mother to infant may occur at delivery or perinatally [3]. A definite acquired prenatal infection has been documented in a few cases, in which the bacterium has been isolated from the placenta, the mother, or the newborn in a short time after birth [12,13,14,15,16,17,18,19,20,21,22,23,24,25].
In general, the neonatal epidemiology of C. koseri is still poorly understood, with few reports about nursery outbreaks. Therefore, the transmission, reservoirs of infection, risk factors, and frequency of asymptomatic colonization need further investigation [25,26,27,28]. An infant with C. koseri infection may be a carrier, and may spread the bacterium in nursery. During outbreaks, many asymptomatic newborns may also be present, with an estimated ratio of 1:25 [26]. Hand carriage by nursery personnel seems to be the main mode of transmission. The source of infection may be the personnel’s hands and/or infants’ umbilicus, and spreading passes on from the nurses’ hands or the infants’ umbilicus to other infants’ umbilicus. The fecal–hand route and environmental origin seem less likely, but possible [27,28]. In cases of nursery outbreak, nasopharyngeal, rectal, and umbilical cord cultures must be taken from the infants, as well as hand and rectal samples from the personnel. Environmental sources should also be investigated with swabs from sinks, incubators, and medical equipment. Infection control procedures must be applied immediately, with frequent handwashing, introduction of routine surveillance cultures, and exclusion of culture-positive staff. The last precaution is considered the most effective, as C. koseri can persist chronically on hands or in the gastrointestinal tract, and then be easily reintroduced into the nursery [28].
Precautions in the nursery are mandatory, as preterm infants are at a higher risk of C. koseri infection, and neurologic symptoms can be vague, even in cases of severe cerebral damage [3,29]. When the diagnosis of C. koseri meningitis has been established, serial neuroimaging must be planned. Ultrasonography can be used for the initial assessment, but MRI is the hallmark for detecting cerebral damage [4]. Although brain abscesses are the main complication, favorable outcomes have been reported [29,30]. Surgical drainage, associated with intravenous antibiotic therapy with meropenem and fosfomycin, should be the treatment of choice in eradicating the infection [29].
As already mentioned, although neonatal C. koseri infection is well known, PPROM and subsequent fetal death due to this microorganism have been fully documented in only two cases [8].
In the first case, the mother had a history of two weeks of vaginal discharge. At admission, the fetal membranes were protruding through the cervical os and an emergency cervical suture was inserted. Vaginal and urine cultures were negative. After 5 days, she was febrile and US detected intrauterine fetal death (IUFD) at 25 wga. The patient fully recovered after septic shock, in which C. koseri was isolated from the blood. The growth of the same bacterium was obtained from the placenta, and fetal blood, lung, liver, and spleen. Histologically, there was severe AC, and neutrophils were observed within the alveoli. Interestingly, in the brain, abundant Gram-negative bacilli were found in the lumen of the penetrating small blood vessels.
The second case was PPROM and IUFD at 18 wga in an asymptomatic mother. Although urine culture isolated Escherichia coli, the placental swab and fetal lung yielded C. koseri. AC and rare pulmonary neutrophils were also observed.
In our case, PPROM occurred at 16 wga and 3 days. The mother presented with abundant vaginal bleeding, but she had never complained of fever. A prophylactic cervical cerclage (Shirodkar type) was inserted 17 days before hospital admission. Other than the report by Chan [8], in the other two, the mothers had cervical cerclage [15,18]. It is highly likely that in all these patients, the cerclage might have been the initial source of infection, and then the bacterium spread through the ascending route.
In our case, C. koseri was isolated postmortem from the following different samples: the placental subamniotic swab and tissue, and fetal blood and lung. Antimicrobial susceptibility testing was performed on the fetal blood and demonstrated intrinsic resistance of the bacterium only, i.e., aminopenicillins. The patient was initially treated with ampicillin by intravenous injection of 2 g every 6 h for two days. The in vitro inefficacy of this therapy might explain the C. koseri isolation from the placenta and fetus.
Histologically, AC and scarce neutrophils were detected in the lungs and into the gastric content. Contrary to Chan’s observation [8], no bacilli, inflammatory response, or parenchymal damage were found in the brain.
C. koseri has a particular brain tropism, and it has been studied in vitro and in animal models. The in vitro studies demonstrated that C. koseri is capable of invading human U937 macrophages and endothelial cells of cerebral capillaries [31,32]. In neonatal rats, fliP favors bacterial macrophage intake, cytokine expression, and brain abscesses [33]. This microorganism has fewer resistance genes than other bacteria, which makes it more susceptible to antibiotics [34]. HPI genes are responsible for pathogenicity; vasculitis of small blood vessels favors hemorrhagic necrosis, tissue destruction, and cavitation. Abscesses from C. koseri typically lack a fibrous capsule. Moreover, the bacteria invade meninges and ependyma, with subsequent parenchymal disruption and hydrocephalus [35,36].
In neonates, the neuropathology of C. koseri has been detailed in only three cases [35,37]. Similarly to the animal model, cerebral necrotizing vasculitis was the main feature, with C. koseri parietal infiltration of the small vessels [29]. Moreover, a 32 kD bacterial membrane protein seems to be involved in meningeal tropism, as it was isolated in cerebrospinal fluid [3].
In our case, cerebral involvement was not observed, either with bacteria or brain damage. This could be explained by the short time of infection and/or the fetal immature immune response.
In conclusion, C. koseri, although rare, can cause PPROM in the early second-trimester and IUFD, through ascending infection and/or a hematogenous route. Particular attention should be given to patients with a cervical cerclage, as it may be the origin of infection. Therefore, vertical transmission of C. koseri as a potential source of infection should not be underestimated, especially in newborns.

Author Contributions

M.P.B.: carried out the pathological diagnosis and wrote the manuscript—original draft preparation, review, and editing; G.C. and M.P.: clinically managed the patient; G.R., L.V., M.B., P.P., R.M. and E.C.: carried out the microbiological diagnosis; A.P.: searched for the bibliography; G.D.D.: provided the draft preparation and writing. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Our investigations were carried out following the rules of the Declaration of Helsinki of 1975, revised in 2013. According to Italian legislation, ethical approval for a single case is not required, as long as the data are kept anonymous and the investigations performed do not imply genetic results.

Informed Consent Statement

The current Italian legislation neither requires the family’s consent or ethical approval for a single case, as long as the data are strictly kept anonymous. Because summoning the mother was not possible, as it would badly interfere with the grieving process, the patient’s consent was completely waived, according to the Italian Authority of Privacy and Data Protection (“Garante della Privacy”: GDPR nr 679/2016; 9/2016 and recent law addition number 424/ 19 July 2018; http://www.garanteprivacy.it).

Data Availability Statement

The data presented in this study are available on request from the corresponding author.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Deveci, A.; Coban, A.Y. Optimum management of Citrobacter koseri infection. Expert Rev. Anti-Infect. Ther. 2014, 12, 1137–1142. [Google Scholar] [CrossRef]
  2. Ward, H.H.; Lauber, P.; Laubach, L.T.; Fishbein, J.; Greenberg, M.R. Citrobacter koseri meningitis with cerebral edema and pneumocephalus in a neonate. Radiol. Case Rep. 2020, 16, 528–530. [Google Scholar] [CrossRef]
  3. Doran, T.I. The Role of Citrobacter in Clinical Disease of Children: Review. Clin. Infect. Dis. 1999, 28, 384–394. [Google Scholar] [CrossRef] [PubMed]
  4. Cuadros, E.N.; Castilla, C.Y.; Algarra, C.M.; Pérez, D.M.; López, B.R.; Martín, F.J.G.; Cardona, A.U. Medical and neurosurgical management of Citrobacter koseri, a rare cause of neonatal meningitis. J. Med. Microbiol. 2014, 63, 144–147. [Google Scholar] [CrossRef]
  5. Martínez-Lage, J.F.; Azorín, L.M.-L.; Almagro, M.J.; Bastida, M.E.; Reyes, S.; Tellez, C. Citrobacter koseri meningitis: A neurosurgical condition? Eur. J. Paediatr. Neurol. 2010, 14, 360–363. [Google Scholar] [CrossRef] [PubMed]
  6. Alviedo, J.N.; Sood, B.G.; Aranda, J.V.; Becker, C. Diffuse Pneumocephalus in Neonatal Citrobacter Meningitis. Pediatrics 2006, 118, e1576–e1579. [Google Scholar] [CrossRef] [PubMed]
  7. Pooboni, S.K.; Mathur, S.K.; Dux, A.; Hewertson, J.; Nichani, S. Pneumocephalus in neonatal meningitis: Diffuse, necrotizing meningo-encephalitis in Citrobacter meningitis presenting with pneumatosis oculi and pneumocephalus. Pediatr. Crit. Care Med. 2004, 5, 393–395. [Google Scholar] [CrossRef]
  8. Chan, Y.F. Second trimester fetal death caused by Citrobacter koseri (diversus) infection: A report of two cases. Aust. N. Z. J. Obstet. Gynaecol. 2002, 42, 106–108. [Google Scholar] [CrossRef]
  9. Tchirikov, M.; Schlabritz-Loutsevitch, N.; Maher, J.; Buchmann, J.; Naberezhnev, Y.; Winarno, A.S.; Seliger, G. Mid-trimester preterm premature rupture of membranes (PPROM): Etiology, diagnosis, classification, international recommendations of treatment options and outcome. J. Peérinat. Med. 2017, 46, 465–488. [Google Scholar] [CrossRef]
  10. Archie, J.G.; Collins, J.S.; Lebel, R.R. Quantitative Standards for Fetal and Neonatal Autopsy. Am. J. Clin. Pathol. 2006, 126, 256–265. [Google Scholar] [CrossRef]
  11. Kraus, F.T.; Redline, R.W.; Gersell, D.J.; Nelson, D.M.; Dicke, J.M. Chapter 5 Inflammation and Infection. In Placental Pathology; Armed Forces Institue of Pathology (AFIP): Washington, DC, USA, 2004; pp. 75–86. [Google Scholar]
  12. Ramos, O.M.; Kaplan, S.L.; Mason, E.O., Jr.; Denson, S.; Pickering, L.K. Successful Moxalactam Therapy for Gram-negative Bacillary Meningitis in Neonates. South. Med. J. 1982, 75, 632–633. [Google Scholar] [CrossRef] [PubMed]
  13. Williams, W.W.; Mariano, J.; Spurrier, M.; Donnell, H.D., Jr.; Breckenridge, R.L., Jr.; Anderson, R.L.; Wachsmuth, I.K.; Thornsberry, C.; Graham, D.R.; Thibeault, D.W.; et al. Nosocomial Meningitis Due to Citrobacter diversus in Neonates: New Aspects of the Epidemiology. J. Infect. Dis. 1984, 150, 229–235. [Google Scholar] [CrossRef]
  14. Morris, J.G., Jr.; Feng-Ying, C.L.; Morrison, C.B.; Gross, R.J.; Khabbaz, R.; Maher, K.O.; Rowe, B.; Israel, E.; Libonati, J.P. Molecular Epidemiology of Neonatal Meningitis Due to Citrobacter diversus: A Study of Isolates from Hospitals in Maryland. J. Infect. Dis. 1986, 154, 409–414. [Google Scholar] [CrossRef] [PubMed]
  15. Finn, A.; Talbot, G.H.; Anday, E.; Skros, M.; Provencher, M.; Hoegg, C. Vertical transmission of Citrobacter diversus from mother to infant. Pediatr. Infect. Dis. J. 1988, 7, 293–294. [Google Scholar] [CrossRef]
  16. Walter, E. Vertical transmission of Citrobacter diversus from mother to infant. Pediatr. Infect. Dis. J. 1988, 7, 675. [Google Scholar] [CrossRef]
  17. Kline, M.W.; Mason, E.O., Jr.; Kaplan, S.L. Characterization of Citrobacter diversus Strains Causing Neonatal Meningitis. J. Infect. Dis. 1988, 157, 101–105. [Google Scholar] [CrossRef]
  18. Dan, M.; Sadan, O. Vertical transmission of Citrobacter diversus from mother to infant. Pediatr. Infect. Dis. J. 1989, 8, 63–64. [Google Scholar] [PubMed]
  19. Goering, R.V.; Ehrenkranz, N.J.; Sanders, C.C.; Sanders, W.E., Jr. Long term epidemiological analysis of Citrobacter diversus in a neonatal intensive care unit. Pediatr. Infect. Dis. J. 1992, 11, 99–104. [Google Scholar] [CrossRef]
  20. Harvey, B.S.; Versalovic, J.; Woods, C.R.; Lupski, J.R.; Koeuth, T. Vertical Transmission of Citrobacter diversus Documented by DNA Fingerprinting. Infect. Control. Hosp. Epidemiol. 1995, 16, 564–569. [Google Scholar] [CrossRef]
  21. Papasian, C.J.; Kinney, J.; Coffman, S.; Hollis, R.J.; Pfaller, M.A. Transmission of Citrobacter koseri from mother to infant documented by ribotyping and pulsed-field gel electrophoresis. Diagn. Microbiol. Infect. Dis. 1996, 26, 63–67. [Google Scholar] [CrossRef]
  22. Mastrobattista, J.M.; Parisi, V.M. Vertical Transmission of a Citrobacter Infection. Am. J. Perinatol. 1997, 14, 465–467. [Google Scholar] [CrossRef]
  23. Agrawal, D.; Mahapatra, A.K. Vertically acquired neonatal citrobacter brain abscess—Case report and review of the literature. J. Clin. Neurosci. 2005, 12, 188–190. [Google Scholar] [CrossRef] [PubMed]
  24. Shenoi, A.N.; Shane, A.L.; Fortenberry, J.D.; Abramowsky, C.; Kamat, P. Spontaneous Pneumocephalus in Vertically Acquired, Late-Onset Neonatal Citrobacter Meningitis. J. Pediatr. 2013, 163, 1791. [Google Scholar] [CrossRef]
  25. Kline, M.W.; Mason, E.O., Jr.; Kaplan, S.L. Epidemiologic marker system for Citrobacter diversus using outer membrane protein profiles. J. Clin. Microbiol. 1989, 27, 1793–1796. [Google Scholar] [CrossRef] [Green Version]
  26. Graham, D.R.; Anderson, R.L.; Ariel, F.E.; Ehrenkranz, N.J.; Rowe, B.; Boer, H.R.; Dixon, R.E. Epidemic Nosocomial Meningitis Due to Citrobacter diversus in Neonates. J. Infect. Dis. 1981, 144, 203–209. [Google Scholar] [CrossRef]
  27. Parry, M.F.; Hutchinson, J.H.; Brown, N.A.; Wu, C.H.; Estreller, L. Gram-negative sepsis in neonates: A nursery outbreak due to hand carriage of Citrobacter diversus. Pediatrics 1980, 65, 1105–1109. [Google Scholar] [CrossRef] [PubMed]
  28. Lin, F.-Y.C.; DeVoe, W.F.; Morrison, C.; Libonati, J.; Powers, P.; Gross, R.J.; Rowe, B.; Israel, E.; Morris, J.G., Jr. Outbreak of neonatal Citrobacter diversus meningitis in a suburban hospital. Pediatr. Infect. Dis. J. 1987, 6, 50–55. [Google Scholar] [CrossRef]
  29. Algubaisi, S.; Bührer, C.; Thomale, U.-W.; Spors, B. Favorable outcome in cerebral abscesses caused by Citrobacter koseri in a newborn infant. IDCases 2014, 2, 22–24. [Google Scholar] [CrossRef] [Green Version]
  30. Straussberg, R.; Harel, L.; Amir, J. Long-Term Outcome of Neonatal Citrobacter koseri (diverus) Meningitis Treated with Imipenem/Meropenem and Surgical Drainage. Infection 2001, 29, 280–282. [Google Scholar] [CrossRef]
  31. Badger, J.L.; Stins, M.F.; Kim, K.S. Citrobacter freundii Invades and Replicates in Human Brain Microvascular Endothelial Cells. Infect. Immun. 1999, 67, 4208–4215. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  32. Townsend, S.M.; Pollack, H.A.; Gonzalez-Gomez, I.; Shimada, H.; Badger, J.L. Citrobacter koseri Brain Abscess in the Neonatal Rat: Survival and Replication within Human and Rat Macrophages. Infect. Immun. 2003, 71, 5871–5880. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Townsend, S.M.; Gonzalez-Gomez, I.; Badger, J.L. fliP influences Citrobacter koseri macrophage uptake, cytokine expression and brain abscess formation in the neonatal rat. J. Med. Microbiol. 2006, 55, 1631–1640. [Google Scholar] [CrossRef] [Green Version]
  34. Yuan, C.; Yin, Z.; Wang, J.; Qian, C.; Wei, Y.; Zhang, S.; Jiang, L.; Liu, B. Comparative Genomic Analysis of Citrobacter and Key Genes Essential for the Pathogenicity of Citrobacter koseri. Front. Microbiol. 2019, 10, 2774. [Google Scholar] [CrossRef] [PubMed]
  35. Foreman, S.D.; Smith, E.E.; Ryan, N.J.; Hogan, G.R. Neonatal Citrobacter meningitis: Pathogenesis of cerebral abscess formation. Ann. Neurol. 1984, 16, 655–659. [Google Scholar] [CrossRef] [PubMed]
  36. Soriano, A.L.; Russell, R.G.; Johnson, D.; Lagos, R.; Sechter, I.; Morris, J.G., Jr. Pathophysiology of Citrobacter diversus neonatal meningitis: Comparative studies in an infant mouse model. Infect. Immun. 1991, 59, 1352–1358. [Google Scholar] [CrossRef] [Green Version]
  37. Tse, G.; Silver, M.; Whyte, H.; Jay, V. Neonatal meningitis and multiple brain abscesses due to Citrobacter diversus. Pediatr. Pathol. Lab. Med. 1997, 17, 977–982. [Google Scholar] [CrossRef]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Bonasoni, M.P.; Comitini, G.; Pati, M.; Russello, G.; Vizzini, L.; Bardaro, M.; Pini, P.; Marrollo, R.; Palicelli, A.; Dalla Dea, G.; et al. Second Trimester Fetal Loss Due to Citrobacter koseri Infection: A Rare Cause of Preterm Premature Rupture of Membranes (PPROM). Diagnostics 2022, 12, 159. https://doi.org/10.3390/diagnostics12010159

AMA Style

Bonasoni MP, Comitini G, Pati M, Russello G, Vizzini L, Bardaro M, Pini P, Marrollo R, Palicelli A, Dalla Dea G, et al. Second Trimester Fetal Loss Due to Citrobacter koseri Infection: A Rare Cause of Preterm Premature Rupture of Membranes (PPROM). Diagnostics. 2022; 12(1):159. https://doi.org/10.3390/diagnostics12010159

Chicago/Turabian Style

Bonasoni, Maria Paola, Giuseppina Comitini, Mariangela Pati, Giuseppe Russello, Loredana Vizzini, Marcellino Bardaro, Pietro Pini, Roberta Marrollo, Andrea Palicelli, Giulia Dalla Dea, and et al. 2022. "Second Trimester Fetal Loss Due to Citrobacter koseri Infection: A Rare Cause of Preterm Premature Rupture of Membranes (PPROM)" Diagnostics 12, no. 1: 159. https://doi.org/10.3390/diagnostics12010159

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop